Show
Sort by
-
Outcomes of SARS-CoV-2 infection post-solid organ transplantation in the cystic fibrosis population
-
- Journal Article
- A1
- open access
Determinants of early Elexacaftor-Tezacaftor-Ivacaftor use in adults with cystic fibrosis and preserved lung function : insights from a European multicenter survey
-
Phase 3 trial of the DPP-1 inhibitor brensocatib in bronchiectasis
-
- Journal Article
- A1
- open access
Mycobacterium avium complex pulmonary disease patients with limited treatment options
-
- Journal Article
- A1
- open access
Impact of COVID-19 infection on lung function and nutritional status amongst individuals with cystic fibrosis : a global cohort study
-
- Journal Article
- A1
- open access
Bronchiectasis and asthma : data from the European Bronchiectasis Registry (EMBARC)
-
- Journal Article
- A1
- open access
Standards for the care of people with cystic fibrosis; establishing and maintaining health
-
- Journal Article
- A1
- open access
Objective sputum colour assessment and clinical outcomes in bronchiectasis : data from the European Bronchiectasis Registry (EMBARC)
-
- Journal Article
- A1
- open access
New concepts in antimicrobial resistance in cystic fibrosis respiratory infections
-
Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis : a global observational study